Seelos Therapeutics Inc
Biotechnology
Healthcare
SEEL
132 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.43
52 week high
6.32
high
1.44
52 week low
1.32
previous Close
1.39
P/E ratio
market cap
139 M
div yield
0
net profit margin
0.00 %
8778.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top